We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+4.33%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$102B
AUM Growth
-$5.35B
(-5%)
Cap. Flow
-$8.86B
Cap. Flow
% of AUM
-8.69%
Top 10 Holdings %
Top 10 Hldgs %
19.26%
Holding
4,322
New
373
Increased
1,162
Reduced
2,180
Closed
377
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.18B |
| 2 |
NLSN
Nielsen Holdings plc
NLSN
|
+$243M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$212M |
| 4 |
AT&T
T
|
+$196M |
| 5 |
UBS Group
UBS
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$736M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$733M |
| 3 |
AABA
Altaba Inc
AABA
|
+$729M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$536M |
| 5 |
TE Connectivity
TEL
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.05% |
| 2 | Financials | 10.64% |
| 3 | Healthcare | 10.15% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Abeona Therapeutics
ABEO
$369M
| $579K | ﹤0.01% |
1,445
+52
| +4% | +$22.7K |
|
3227
ANI Pharmaceuticals
ANIP
$1.83B
| $578K | ﹤0.01% |
8,659
+2,028
| +31% | +$127K |
|
3228
TechTarget
TTGT
$325M
| $578K | ﹤0.01% |
+20,357
| New | +$488K |
|
|
AAV
3229
DELISTED
Advantage Oil & Gas Ltd
AAV
| $577K | ﹤0.01% |
186,054
-95,056
| -34% | -$294K |
|
3230
Barclays
BCS
$93.4B
| $574K | ﹤0.01% |
59,842
+37,299
| +165% | +$404K |
|
|
TCP
3231
DELISTED
TC Pipelines LP
TCP
| $573K | ﹤0.01% |
22,039
-4,120
| -16% | -$115K |
|
|
EEQ
3232
DELISTED
Enbridge Energy Management Llc
EEQ
| $572K | ﹤0.01% |
57,701
-6,968
| -11% | -$62.7K |
|
3233
iShares MSCI Canada ETF
EWC
$6.17B
| $571K | ﹤0.01% |
20,030
| – | – |
|
3234
Ichor Holdings
ICHR
$2.61B
| $570K | ﹤0.01% |
26,843
+6,087
| +29% | +$145K |
|
3235
Fidelity International High Dividend ETF
FIDI
$366M
| $568K | ﹤0.01% |
25,671
-31,999
| -55% | -$739K |
|
3236
MACOM Technology Solutions
MTSI
$19B
| $568K | ﹤0.01% |
24,681
+1,495
| +6% | +$31.8K |
|
3237
Tactile Systems Technology
TCMD
$636M
| $568K | ﹤0.01% |
10,916
+678
| +7% | +$29.5K |
|
|
ARC
3238
DELISTED
ARC Document Solutions, Inc.
ARC
| $561K | ﹤0.01% |
317,140
-14,722
| -4% | -$30.7K |
|
3239
Quad
QUAD
$509M
| $559K | ﹤0.01% |
26,804
-12,156
| -31% | -$266K |
|
|
ACHN
3240
DELISTED
Achillion Pharmaceuticals
ACHN
| $559K | ﹤0.01% |
197,605
+14,539
| +8% | +$49.5K |
|
|
BHBK
3241
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $557K | ﹤0.01% |
25,084
+5,205
| +26% | +$109K |
|
3242
Financial Institutions
FISI
$812M
| $556K | ﹤0.01% |
16,917
-3,240
| -16% | -$104K |
|
3243
Medpace
MEDP
$16.1B
| $555K | ﹤0.01% |
12,906
-2,767
| -18% | -$112K |
|
3244
Axcelis
ACLS
$3.85B
| $554K | ﹤0.01% |
27,992
-2,891
| -9% | -$63.6K |
|
3245
Compañía de Cervecerías Unidas
CCU
$2.16B
| $552K | ﹤0.01% |
22,165
-21,271
| -49% | -$573K |
|
3246
DXP Enterprises
DXPE
$2.4B
| $552K | ﹤0.01% |
14,473
-994
| -6% | -$38.3K |
|
|
HSII
3247
DELISTED
Heidrick & Struggles
HSII
| $551K | ﹤0.01% |
15,733
+1,367
| +10% | +$49.5K |
|
|
SUP
3248
DELISTED
Superior Industries International
SUP
| $548K | ﹤0.01% |
30,634
-2,384
| -7% | -$39K |
|
3249
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $547K | ﹤0.01% |
+10,542
| New | +$546K |
|
3250
Lifecore Biomedical
LFCR
$164M
| $547K | ﹤0.01% |
36,714
-3,368
| -8% | -$46.8K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2018 Portfolio in Review
As of Q2 2018, Credit Suisse held 4,322 positions worth $102B, down 5% from $107B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Credit Suisse withdrew a net $8.86B in Q2 2018, closing 377 positions and reducing 2,180 holdings. Its most notable exit was Time Warner Inc, an estimated $736M position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Credit Suisse opened a new position in Optimum Communications Inc worth $41.9M.
- Credit Suisse's largest Q2 2018 buy was Optimum Communications Inc: 2,458,067 shares worth $41.9M.
- Credit Suisse added most to UnitedHealth in Q2 2018, an estimated $1.18B increase.
- Credit Suisse's biggest Q2 2018 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $733M.
- Credit Suisse fully exited Time Warner Inc in Q2 2018, selling an estimated $736M.
- Credit Suisse's ten largest holdings make up 19% of its $102B portfolio in Q2 2018.
- Credit Suisse opened 373 new positions and closed 377 in Q2 2018.
- Credit Suisse's portfolio value fell 5% quarter-over-quarter to $102B.
Based on Credit Suisse's 13F filing for Q2 2018, filed 14 Aug 2018.